UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 16 2024 - 10:48AM
Business Wire
NOTE: The new presentation time for Aurinia’s presentation at
the 2024 Bloom Burton & Co. Healthcare Investor Conferences is
4:00 to 4:30 PM Eastern Time. This event is presentation only.
Webcast Details remain the same.
The updated release reads:
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the
Company) today announced that it will attend the 2024 Bloom Burton
& Co. Healthcare Investor Conference taking place at the Metro
Toronto Convention Centre in Toronto from April 16-17, 2024.
Aurinia management will host one-on-one meetings with investors
and will host a presentation on Tuesday, April 16, from 4:00 to
4:30 PM Eastern Time. A live webcast of the session will be
available on the investor section of Aurinia’s website, which can
be found here.
About Aurinia
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical
company focused on delivering therapies to people living with
autoimmune diseases with high unmet medical needs. In January 2021,
the Company introduced LUPKYNIS® (voclosporin), the first
FDA-approved oral therapy dedicated to the treatment of adult
patients with active lupus nephritis. The Company’s head office is
in Edmonton, Alberta, its U.S. commercial office is in Rockville,
Maryland. The Company focuses its development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240416949452/en/
Media and Investor Inquiries: Andrea Christopher
Corporate Communications and Investor Relations, Aurinia
achristopher@auriniapharma.com ir@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024